Literature DB >> 18475715

Dimeric and polymeric IgA, but not monomeric IgA, enhance the production of IL-6 by human renal mesangial cells.

T J Reterink1, W E Schroeijers, L A Es, M R Daha.   

Abstract

Depositions of IgA in the renal glomerular mesangial area are a hallmark of IgA nephropathy, and are thought to be crucial for the onset of inflammation processes in IgA nephropathy. In this report we show that human mesangial cells (MC) in vitro bind IgA and that binding of IgA enhances the production of IL-6 by MC. Furthermore we show that the size of IgA is crucial in its capability to enhance IL-6 production. Monomeric IgA does not affect basic IL-6 production, whereas dimeric and polymeric IgA enhance IL-6 production up to 3- to 9-fold respectively. Additional studies demonstrate that enhanced IL-6 production by MC is not accompanied by increased proliferation of human mesangial cells, a finding which is distinct from that found with rat mesangial cells. Taken together, these fmdings suggest that deposition of dimeric and polymeric IgA in the mesangial area of human kidneys in IgA nephropathy may amplify local inflammation.

Entities:  

Year:  1996        PMID: 18475715      PMCID: PMC2365790          DOI: 10.1155/S0962935196000269

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  21 in total

1.  Clearance of polymeric IgA aggregates in humans.

Authors:  D Roccatello; G Picciotto; R Coppo; G Piccoli; A Molino; G Cacace; A Amore; A Amoroso; G Quattrocchio; L M Sena
Journal:  Am J Kidney Dis       Date:  1989-11       Impact factor: 8.860

Review 2.  The biology of interleukin-6.

Authors:  T Kishimoto
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

3.  IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.

Authors:  R Kirnbauer; A Köck; T Schwarz; A Urbanski; J Krutmann; W Borth; D Damm; G Shipley; J C Ansel; T A Luger
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

4.  Interleukin 6 is an autocrine growth factor for mesangial cells.

Authors:  C Ruef; K Budde; J Lacy; W Northemann; M Baumann; R B Sterzel; D L Coleman
Journal:  Kidney Int       Date:  1990-08       Impact factor: 10.612

5.  Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages.

Authors:  J Bauer; U Ganter; T Geiger; U Jacobshagen; T Hirano; T Matsuda; T Kishimoto; T Andus; G Acs; W Gerok
Journal:  Blood       Date:  1988-10       Impact factor: 22.113

6.  Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokines.

Authors:  J Floege; N Topley; J Hoppe; T B Barrett; K Resch
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

7.  Soluble aggregates of IgG and immune complexes enhance IL-6 production by renal mesangial cells.

Authors:  M E van den Dobbelsteen; F J van der Woude; W E Schroeijers; L A van Es; M R Daha
Journal:  Kidney Int       Date:  1993-03       Impact factor: 10.612

8.  IgG1 plasmacytosis in interleukin 6 transgenic mice.

Authors:  S Suematsu; T Matsuda; K Aozasa; S Akira; N Nakano; S Ohno; J Miyazaki; K Yamamura; T Hirano; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies.

Authors:  A W van den Wall Bake; W E Beyer; J H Evers-Schouten; J Hermans; M R Daha; N Masurel; L A van Es
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

10.  Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.

Authors:  J Van Snick; S Cayphas; A Vink; C Uyttenhove; P G Coulie; M R Rubira; R J Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

View more
  3 in total

1.  Profiling of autoantibodies in IgA nephropathy, an integrative antibiomics approach.

Authors:  Tara K Sigdel; Sang Hoon Woo; Hong Dai; Purvesh Khatri; Li Li; Bryan Myers; Minnie M Sarwal; Richard A Lafayette
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

Review 2.  Corticosteroids in IgA Nephropathy: Lessons from Recent Studies.

Authors:  Rosanna Coppo
Journal:  J Am Soc Nephrol       Date:  2016-09-26       Impact factor: 10.121

3.  Synergistic effect of mesangial cell-induced CXCL1 and TGF-β1 in promoting podocyte loss in IgA nephropathy.

Authors:  Li Zhu; Qingxian Zhang; Sufang Shi; Lijun Liu; Jicheng Lv; Hong Zhang
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.